描述
Multi-panel analysis results labeled (c) and (d) from the synbiotic IBS-D trial present additional symptom domain comparisons.
Figure 22
ChartSource Paper
The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant …Cite This Figure
![Figure 22: Multi-panel analysis results labeled (c) and (d) from the synbiotic IBS-D trial present additional symptom domain comparisons.]() > Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." *Nutrients*, 2020. PMID: [32635661](https://pubmed.ncbi.nlm.nih.gov/32635661/)
<figure> <img src="" alt="Multi-panel analysis results labeled (c) and (d) from the synbiotic IBS-D trial present additional symptom domain comparisons." /> <figcaption>Figure 22. Multi-panel analysis results labeled (c) and (d) from the synbiotic IBS-D trial present additional symptom domain comparisons.<br> Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32635661/">32635661</a></figcaption> </figure>
相关证据
B
Bifidobacterium longum 用于 Irritable Bowel Syndrome (IBS)
B
等级 B · 4 项研究
Galactooligosaccharides (GOS) 用于 Irritable Bowel Syndrome (IBS)
B
等级 B · 3 项研究
Lactobacillus acidophilus 用于 Irritable Bowel Syndrome (IBS)
D
等级 B · 3 项研究
Fructooligosaccharides (FOS) 用于 Irritable Bowel Syndrome (IBS)
等级 D · 2 项研究